LONDON, April 16 (Reuters) - Drugmaker GlaxoSmithKline said on Wednesday it was investigating allegations ofbribery involving some of its staff in Jordan and Lebanon,following earlier claims of corruption in China, Iraq andPoland.
"GSK can confirm we are investigating allegations regardingthe activity of a small number of individuals in our operationsin Jordan and Lebanon," the company said in statement.
"We started investigating using internal and external teamsas soon as we became aware of these claims. These investigationshave not yet concluded." (Reporting by Ben Hirschler; Editing by Greg Mahlich)
Glaxosmithkline (GSK)
